Provided by Tiger Trade Technology Pte. Ltd.

AIxCrypto Holdings, Inc.

2.74
+0.08003.01%
Post-market: 2.740.00000.00%19:57 EST
Volume:103.47K
Turnover:283.84K
Market Cap:14.14M
PE:-0.42
High:2.84
Open:2.76
Low:2.61
Close:2.66
52wk High:8.81
52wk Low:1.61
Shares:5.16M
Float Shares:2.03M
Volume Ratio:0.60
T/O Rate:5.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.4964
EPS(LYR):-17.5526
ROE:-39.69%
ROA:-18.87%
PB:5.78
PE(LYR):-0.16

Loading ...

Company Profile

Company Name:
AIxCrypto Holdings, Inc.
Exchange:
NASDAQ
Establishment Date:
1996
Employees:
4
Office Location:
5857 Owens Avenue,Suite 300,Carlsbad,California,United States
Zip Code:
92008
Fax:
- -
Introduction:
Qualigen Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a patent-protected rapid, onsite immunoassay testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, an oligonucleotide-based drug candidate to treat various nucleolin-expressing cancers, including liquid and solid tumors; QN-165, a drug candidate for the potential broad-spectrum treatment of infectious diseases, such as COVID-19; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and selective target antigen removal system, a therapeutic device to remove circulating tumor cells, viruses, inflammation factors, and immune checkpoints. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.

Directors

Name
Position
Jie Sheng
Independent Chairman & Director
Kevin Richardson II
Executive Director & Co-Chief Executive Officer
Chad Chen
Independent Director
Kevin Chen
Independent Director
Koti Meka
Executive Director & Chief Financial Officer

Shareholders

Name
Position
Jiawei Wang
Co-Chief Executive Officer
Kevin Richardson II
Executive Director & Co-Chief Executive Officer
Koti Meka
Executive Director & Chief Financial Officer